David G Harrison Selected Research

C-Reactive Protein

7/2023	High tissue-sodium associates with systemic inflammation and insulin resistance in obese individuals.
1/2020	Inflammation in Hypertension.
1/2020	Effects of Interleukin-1β Inhibition on Blood Pressure, Incident Hypertension, and Residual Inflammatory Risk: A Secondary Analysis of CANTOS.
1/2005	Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David G Harrison Research Topics

Disease

90	Hypertension (High Blood Pressure) 04/2024 - 08/2002
43	Inflammation (Inflammations) 04/2024 - 09/2003
24	Atherosclerosis 12/2022 - 01/2002
13	Cardiovascular Diseases (Cardiovascular Disease) 07/2023 - 08/2002
11	Vascular Diseases (Vascular Disease) 01/2018 - 11/2002
5	Heart Failure 01/2021 - 05/2002
5	Coronary Artery Disease (Coronary Atherosclerosis) 03/2016 - 03/2003
4	Fibrosis (Cirrhosis) 01/2022 - 03/2015
4	Essential Hypertension 01/2022 - 08/2017
3	Insulin Resistance 07/2023 - 03/2009
3	Necrosis 01/2021 - 03/2015
3	Atrial Fibrillation 06/2020 - 11/2002
3	Thrombosis (Thrombus) 01/2020 - 11/2002
3	Hypertrophy 01/2020 - 09/2003
3	Neoplasms (Cancer) 01/2018 - 10/2005
3	Vascular Remodeling 12/2014 - 01/2013
3	Atherosclerotic Plaque (Atheroma) 06/2010 - 02/2004
3	Coronary Disease (Coronary Heart Disease) 05/2010 - 03/2003
2	Bites and Stings (Sting) 05/2024 - 04/2023
2	Obesity 07/2023 - 11/2012
2	Periodontitis 11/2021 - 01/2019
2	Myocardial Infarction 01/2020 - 03/2011
2	Hypoxia (Hypoxemia) 12/2014 - 02/2004
2	Weight Gain 07/2014 - 07/2011
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 03/2014 - 01/2014
2	Pathologic Processes 01/2014 - 11/2011
2	Type 2 Diabetes Mellitus (MODY) 01/2014 - 05/2007

Drug/Important Bio-Agent (IBA)

50	Angiotensin IIIBA 04/2024 - 10/2002
24	Superoxides (Superoxide)IBA 12/2020 - 08/2002
23	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 08/2002
21	SaltsIBA 01/2020 - 04/2003
20	CytokinesIBA 12/2022 - 06/2003
18	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2019 - 03/2003
13	SodiumIBA 07/2023 - 11/2008
10	Proteins (Proteins, Gene)FDA Link 04/2024 - 06/2003
10	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2020 - 08/2002
10	EnzymesIBA 01/2018 - 08/2002
9	isolevuglandinIBA 04/2024 - 10/2017
9	Superoxide DismutaseIBA 01/2020 - 08/2002
9	Interleukin-17 (Interleukin 17)IBA 07/2017 - 02/2010
8	Desoxycorticosterone Acetate (DOCA)FDA Link 07/2017 - 04/2003
7	Interleukin-6 (Interleukin 6)IBA 07/2023 - 05/2010
7	AntioxidantsIBA 06/2020 - 01/2007
6	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 01/2016 - 10/2002
6	Oxidants (Oxidizing Agents)IBA 01/2016 - 06/2003
5	InterferonsIBA 05/2024 - 07/2013
5	Acetates (Acetic Acid Esters)FDA Link 01/2020 - 04/2003
5	Desoxycorticosterone (Deoxycorticosterone)IBA 01/2020 - 04/2003
5	CatalaseIBA 01/2019 - 04/2003
5	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2018 - 04/2003
5	AngiotensinsIBA 05/2016 - 12/2006
5	CollagenIBA 05/2016 - 02/2014
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 10/2007
5	Norepinephrine (Noradrenaline)FDA LinkGeneric 08/2015 - 11/2008
5	Nitric Oxide Synthase (NO Synthase)IBA 11/2011 - 11/2002
4	Glucose (Dextrose)FDA LinkGeneric 07/2023 - 03/2016
4	C-Reactive ProteinIBA 07/2023 - 01/2005
4	Oxidoreductases (Dehydrogenase)IBA 01/2019 - 09/2003
4	NADP (NADPH)IBA 01/2019 - 08/2005
4	sapropterin (tetrahydrobiopterin)FDA Link 01/2018 - 04/2003
3	LeptinIBA 07/2023 - 07/2014
3	CalciumIBA 01/2023 - 11/2008
3	AntigensIBA 01/2021 - 05/2015
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2006
3	Sirtuin 3IBA 12/2020 - 08/2017
3	LipidsIBA 06/2020 - 08/2008
3	Phosphotransferases (Kinase)IBA 01/2019 - 09/2003
3	Oxygen (Dioxygen)IBA 01/2018 - 01/2007
3	tempolIBA 01/2016 - 05/2007
3	Protein Isoforms (Isoforms)IBA 07/2011 - 09/2002
2	Antihypertensive Agents (Antihypertensives)IBA 04/2024 - 11/2021
2	Peptides (Polypeptides)IBA 04/2024 - 01/2022
2	InterleukinsIBA 01/2021 - 01/2018
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 11/2014
2	InflammasomesIBA 01/2020 - 01/2018
2	Amiloride (Midamor)FDA LinkGeneric 01/2019 - 10/2017
2	LigandsIBA 01/2018 - 12/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 02/2004
2	Messenger RNA (mRNA)IBA 01/2018 - 01/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 06/2003
2	NitrogenIBA 01/2018 - 01/2007
2	GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA 01/2018 - 01/2014
2	ebselenIBA 08/2017 - 01/2005
2	MitoTEMPOIBA 08/2017 - 07/2010
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 04/2016 - 10/2015
2	Hydralazine (Apresoline)FDA LinkGeneric 01/2016 - 07/2010
2	AngiotensinogenIBA 06/2015 - 03/2015
2	Recombinases (Recombinase)IBA 03/2014 - 01/2014
2	Tyrosine (L-Tyrosine)FDA Link 07/2013 - 09/2003
2	acetovanillone (apocynin)IBA 06/2012 - 03/2009
2	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 06/2012 - 01/2010
2	ApolipoproteinsIBA 07/2011 - 06/2010
2	Peroxynitrous Acid (Peroxynitrite)IBA 11/2009 - 02/2008
2	Hormones (Hormone)IBA 11/2008 - 12/2006
2	multidrug resistance-associated protein 1IBA 04/2007 - 09/2005
2	Glutathione (Reduced Glutathione)IBA 04/2007 - 03/2006
2	Glutathione Disulfide (GSSG)FDA LinkGeneric 04/2007 - 03/2006

Therapy/Procedure

9	Therapeutics 04/2024 - 11/2012
2	Drug Therapy (Chemotherapy) 12/2022 - 01/2022
2	Ligation 07/2011 - 06/2010